- Home
- CRSR vs LXRX Comparison
CRSR vs LXRX Comparison
Compare CRSR & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRSR | LXRX |
|---|---|---|
| Founded | 1994 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Manufacturing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 616.0M | 547.4M |
| IPO Year | 2020 | 2000 |
Fundamental Metrics
Financial Performance| Metric | CRSR | LXRX |
|---|---|---|
| Price | $5.18 | $1.55 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 2 |
| Target Price | ★ $8.50 | $4.15 |
| AVG Volume (30 Days) | 1.5M | ★ 2.3M |
| Earning Date | 05-05-2026 | 03-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 87.37 | 77.78 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,472,480,000.00 | $49,803,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $6.90 | $22.16 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 11.86 | ★ 60.24 |
| 52 Week Low | $4.48 | $0.32 |
| 52 Week High | $10.41 | $1.83 |
Technical Indicators
Market Signals| Indicator | CRSR | LXRX |
|---|---|---|
| Relative Strength Index (RSI) | 42.66 | 50.52 |
| Support Level | $4.48 | $1.08 |
| Resistance Level | $6.19 | $1.65 |
| Average True Range (ATR) | 0.29 | 0.13 |
| MACD | -0.05 | -0.02 |
| Stochastic Oscillator | 0.00 | 30.88 |
Price Performance
Historical ComparisonAbout CRSR Corsair Gaming Inc.
Corsair Gaming Inc is engaged in the business of providing high-performance gear for gamers and content creators. The product portfolio includes Cases, Keyboards, Mice, Headsets, Power Supplies, Gaming Computers, Gaming Chairs, Mousepads, and other related products. The company operates in two segments namely, Gamer and Creator peripherals, which is the key revenue-generating segment; and Gaming Components and Systems. Geographically, the group derives revenue from the Americas, Europe and the Middle East, and the Asia Pacific.
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.